ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 56 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,500 | -5.7% | 1,000 | 0.0% | 0.00% | – |
| Q2 2023 | $1,590 | +121.8% | 1,000 | 0.0% | 0.00% | – |
| Q1 2023 | $717 | +23.6% | 1,000 | 0.0% | 0.00% | – |
| Q4 2022 | $580 | -42.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -50.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | -97.7% | 1,000 | -96.0% | 0.00% | -100.0% |
| Q2 2021 | $88,000 | -64.1% | 25,110 | +1.1% | 0.00% | -66.7% |
| Q1 2021 | $245,000 | -53.6% | 24,837 | -49.0% | 0.01% | -58.6% |
| Q4 2020 | $528,000 | +5.4% | 48,673 | 0.0% | 0.03% | -6.5% |
| Q3 2020 | $501,000 | -49.7% | 48,673 | +2.0% | 0.03% | -52.3% |
| Q2 2020 | $996,000 | +76.9% | 47,712 | -17.2% | 0.06% | +41.3% |
| Q1 2020 | $563,000 | – | 57,658 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |